ARD1 Stabilization of TSC2 Suppresses Tumorigenesis Through the mTOR Signaling Pathway
- 9 February 2010
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Signaling
- Vol. 3 (108) , ra9
- https://doi.org/10.1126/scisignal.2000590
Abstract
Acetylation by ARD1 of an inhibitor of mammalian target of rapamycin may inhibit cancer growth.Keywords
This publication has 66 references indexed in Scilit:
- KEAP1 E3 Ligase-Mediated Downregulation of NF-κB Signaling by Targeting IKKβMolecular Cell, 2009
- A genome-wide RNAi screen reveals multiple regulators of caspase activationThe Journal of cell biology, 2007
- Dysfunctional KEAP1–NRF2 Interaction in Non-Small-Cell Lung CancerPLoS Medicine, 2006
- X chromosomal and autosomal loss of heterozygosity and microsatellite instability in human cervical carcinomaInternational Journal of Gynecologic Cancer, 2006
- Purified recombinant hARD1 does not catalyse acetylation of Lys532 of HIF‐1α fragments in vitroFEBS Letters, 2006
- Interaction between HIF‐1α (ODD) and hARD1 does not induce acetylation and destabilization of HIF‐1αFEBS Letters, 2005
- Role and Regulation of Starvation-Induced Autophagy in the Drosophila Fat BodyDevelopmental Cell, 2004
- Lineage Infidelity of MDA-MB-435 CellsCancer Research, 2004
- dS6K-regulated cell growth is dPKB/dPI(3)K-independent, but requires dPDK1Nature Cell Biology, 2002
- Tor, a Phosphatidylinositol Kinase Homologue, Controls Autophagy in YeastJournal of Biological Chemistry, 1998